Alprazolam
Alprazolam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Alprazolam; Generic name: ALPRAZOLAM; Drug class: Benzodiazepine [EPC].
| Brand name | Alprazolam |
|---|---|
| Generic name | ALPRAZOLAM |
| Drug class | Benzodiazepine [EPC] |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults. Alprazolam tablets are a benzodiazepine indicated for the: Acute treatment of generalized anxiety disorder in adults. ( 1 ) Treatment of panic disorder with or without agoraphobia in adults. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Generalized Anxiety Disorder: ( 2.1 ) Recommended starting oral dosage is 0.25 mg to 0.5 mg three times daily. Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4 mg, given in divided doses. Use the lowest possible effective dose and frequently assess the need for continued treatment. Panic Disorder: Recommended starting oral dosage is 0.5 mg three times daily. The dosage may be increased at intervals of every 3 to 4 da |
| Warnings | WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings |
| Active ingredient(s) | ALPRAZOLAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ffcdbab-17e4-4395-8155-5b6ad00be6c2 |